文献速递妇科

子宫腺肌病的无创诊断:影像学诊断准确性的结构化综述与Meta分析

Noninvasive Diagnosis of Adenomyosis: A Structured Review and Meta-analysis of Diagnostic Accuracy in Imaging.
PubMed 文献 · J Minim Invasive Gynecol · 2019-11-08

该系统综述与Meta分析检索2000年1月至2019年6月数据库,纳入10项研究,比较经阴道超声(TVUS)与磁共振成像(MRI)诊断子宫腺肌病的准确性。MRI、二维TVUS、三维TVUS及TVUS的汇总敏感度分别为78%、74%、84%、78%,特异度分别为88%、76%、84%、78%,各模态汇总AUC无显著差异(p≥.4)。作者推荐TVUS作为一线诊断影像方法,TVUS结论不明确时以MRI作为二线方法。

要点

  • MRI汇总敏感度78%、特异度88%,二维TVUS分别为74%、76%。
  • 三维TVUS汇总敏感度84%、特异度84%,TVUS汇总敏感度78%、特异度78%。
  • 各影像模态汇总AUC无显著差异(p≥.4),作者推荐TVUS一线、MRI二线。

核心结论

  • 作者认为TVUS与MRI均为诊断子宫腺肌病的良好且可比的无创影像方法,推荐TVUS作为一线诊断影像方法,TVUS结论不明确时以MRI作为二线方法。

研究设计与样本

  • 系统综述与Meta分析,检索Cochrane Central Register of Controlled Trials、EMBASE及PubMed或MEDLINE数据库2000年1月至2019年6月的文献。
  • 纳入报告影像方法诊断准确性并以组织病理学为参考标准的研究,共纳入10项研究。
  • Meta分析纳入827例接受二维或三维TVUS的患者和317例接受MRI的患者,子宫腺肌病总体患病率为40%。

主要发现

  • MRI汇总敏感度78%(95%CI 70%-84%)、特异度88%(95%CI 83%-92%)、阳性似然比6.8(95%CI 4.5%-10%)、阴性似然比0.25(95%CI 0.18%-0.35%)、汇总AUC 0.77。
  • 二维TVUS汇总敏感度74%(95%CI 68%-79%)、特异度76%(95%CI 71%-79%)、阳性似然比3(95%CI 2.5%-3.7%)、阴性似然比0.34(95%CI 0.27%-0.43%)、汇总AUC 0.7。
  • 三维TVUS汇总敏感度84%(95%CI 77%-89%)、特异度84%(95%CI 77%-89%)、阳性似然比5.2(95%CI 3.6%-7.4%)、阴性似然比0.19(95%CI 0.13%-0.28%)、汇总AUC 0.83。
  • TVUS(未区分二维或三维)汇总敏感度78%(95%CI 73%-82%)、特异度78%(95%CI 74%-81%)、阳性似然比3.5(95%CI 3%-4.2%)、阴性似然比0.28(95%CI 0.23%-0.34%)、汇总AUC 0.73。
  • 所有影像模态的汇总AUC差异无统计学显著(all: p≥.4)。

关键数值与推荐

  • MRI汇总敏感度78%(95%CI 70%-84%)、特异度88%(95%CI 83%-92%)、阳性似然比6.8(95%CI 4.5%-10%)、阴性似然比0.25(95%CI 0.18%-0.35%)、汇总AUC 0.77。
  • 二维TVUS汇总敏感度74%(95%CI 68%-79%)、特异度76%(95%CI 71%-79%)、阳性似然比3(95%CI 2.5%-3.7%)、阴性似然比0.34(95%CI 0.27%-0.43%)、汇总AUC 0.7。
  • 三维TVUS汇总敏感度84%(95%CI 77%-89%)、特异度84%(95%CI 77%-89%)、阳性似然比5.2(95%CI 3.6%-7.4%)、阴性似然比0.19(95%CI 0.13%-0.28%)、汇总AUC 0.83。
  • TVUS汇总敏感度78%(95%CI 73%-82%)、特异度78%(95%CI 74%-81%)、阳性似然比3.5(95%CI 3%-4.2%)、阴性似然比0.28(95%CI 0.23%-0.34%)、汇总AUC 0.73。
  • 所有影像模态汇总AUC差异无统计学显著(all: p≥.4)。

临床怎么用

  • 作者推荐TVUS作为诊断子宫腺肌病的一线诊断影像方法。
  • 作者推荐TVUS结论不明确时以MRI作为二线诊断影像方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To conduct a systematic review and meta-analysis to evaluate imaging methods used to diagnose adenomyosis. DATA SOURCES: A thorough search was completed through the Cochrane Central Register of Controlled Trials, EMBASE, and PubMed or MEDLINE databases from January 2000 to June 2019. METHODS OF STUDY SELECTION: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and the Quality Assessment of Diagnostic Accuracy Studies 2 tool, studies reporting the diagnostic accuracy of an imaging method and histopathology as a reference standard were selected and prospectively registered in the International Prospective Register of Systematic Reviews. Statistical analysis was performed using the R-package Meta-Analysis of Diagnostic Accuracy. TABULATION, INTEGRATION, AND RESULTS: Of the 1168 records identified, 10 studies were included in the meta-analysis, and these included 827 patients undergoing 2- or 3-dimensional transvaginal ultrasound (TVUS) and 317 patients undergoing magnetic resonance imaging (MRI). The risk of bias was low or unclear for all Quality Assessment of Diagnostic Accuracy Studies domains. The overall prevalence of adenomyosis was 40%. Overall MRI, 2-dimensional TVUS, 3-dimensional TVUS, and TVUS had the following aggregated diagnostic qualities (95% confidence interval): sensitivity of 78% (70%-84%), 74% (68%-79%), 84% (77%-89%), 78% (73%-82%); specificity of 88% (83%-92%), 76% (71%-79%), 84% (77%-89%), 78% (74%-81%); positive likelihood ratio of 6.8 (4.5%-10%), 3 (2.5%-3.7%), 5.2 (3.6%-7.4%), 3.5 (3%-4.2%); negative likelihood ratio of 0.25 (0.18%-0.35%), 0.34 (0.27%-0.43%), 0.19 (0.13%-0.28%), 0.28 (0.23%-0.34%); and pooled area under the operator curve of 0.77, 0.7, 0.83, 0.73, respectively. The pooled area under the operator curve for all modalities was not significantly different (all: p ≥.4). CONCLUSION: As a result of the systemic review and meta-analysis, we identified TVUS and MRI as good and comparable noninvasive imaging methods for diagnosing adenomyosis, leading us to recommend TVUS as the first-line diagnostic imaging method and MRI as a second-line method, if TVUS is inconclusive.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Tellum T, Nygaard S, Lieng M, et al. Noninvasive Diagnosis of Adenomyosis: A Structured Review and Meta-analysis of Diagnostic Accuracy in Imaging. J Minim Invasive Gynecol. 2019. PMID: 31712162. doi:10.1016/j.jmig.2019.11.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。